期刊文献+

度洛西汀治疗骨关节炎慢性疼痛的研究进展 被引量:11

下载PDF
导出
摘要 度洛西汀属于5-羟色胺和去甲肾上腺素再摄取抑制剂,其最开始用于治疗严重抑郁症。目前国外研究显示度洛西汀可以有效减轻骨关节炎所致的慢性疼痛,提高膝关节功能,且具有较好的安全性和耐受性。美国食品药品监督管理局(FDA)亦已批准度洛西汀用于治疗骨关节炎所致的慢性疼痛。本文首次就度洛西汀治疗骨关节炎疼痛的作用机制、有效性、安全性及耐受性做一综述,以期加深国内骨科及疼痛科医生对该药的了解,为治疗骨关节慢性疼痛提供了一个新的药物。
出处 《中国疼痛医学杂志》 CAS CSCD 2016年第7期532-535,共4页 Chinese Journal of Pain Medicine
基金 国家自然科学基金(编号:81472089) 广州市科技计划项目(编号:2014Y2-00084)
  • 相关文献

参考文献29

  • 1Murphy L,Schwartz TA,Helmick CG,et al.Lifetime risk of symptomatic knee osteoarthritis.Arthritis and rheumatism,2008,59(9):1207-1213.
  • 2罗剑刚,李慧,杨聪娴.COX-2选择性抑制剂治疗疼痛的研究进展[J].中国疼痛医学杂志,2012,18(2):66-69. 被引量:36
  • 3Goldstein DJ,Lu Y,Detke MJ,et al.Duloxetine vs.placebo in patients with painful diabetic neuropathy.Pain,2005,116(1-2):109-118.
  • 4Wernicke JF,Pritchett YL,D'Souza DN,et al.A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.Neurol,2006,67(8):1411-1420.
  • 5Arnold LM,Lu Y,Crofford LJ,et al.A double-blind,multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.Arthritis and rheumatism,2004,50(9):2974-2984.
  • 6Skljarevski V,Desaiah D,Liu-Seifert H,et al.Efficacy and safety of duloxetine in patients with chronic low back pain.Spine,2010,35(13):E578-585.
  • 7Chappell AS,Ossanna MJ,Liu-Seifert H,et al.Duloxetine,a centrally acting analgesic,in the treatment of patients with osteoarthritis knee pain:a 13-week,randomized,placebo-controlled trial.Pain,2009,146(3):253-260.
  • 8Chappell AS,Desaiah D,Liu-Seifert H,et al.A doubleblind,randomized,placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.Pain practice:the official journal of World Institute of Pain,2011,11(1):33-41.
  • 9Kidd BL.Osteoarthritis and joint pain.Pain,2006,123(1-2):6-9.
  • 10De Santana JM,Sluka KA.Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain.Current pain and headache reports,2008,12(5):338-343.

二级参考文献46

  • 1方忠,李锋,熊伟,李光辉,敦先礼.特异性COX-2抑制剂保护骨关节炎软骨的临床观察[J].实用骨科杂志,2006,12(1):29-32. 被引量:10
  • 2Miyamoto T, Ogino N, Y amamoto S, et al. Purific- ation of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem, 1976, 251 : 2629 - 2636,.
  • 3Xie WL, Chipman JG, Roberts on DL, et al. Expre- ssion of a mitogen 2 responsive gene encoding prostaglandin synthase is regulated by mRNA spli- cing. Proc Natl Acad Sci, 1991, 88:2692- 2696.
  • 4Chandrasekharan NV, Dai H, Roos KL, et al. COX- 3, a cyclooxygenase-1 variant inhibited by acetam- inophen and other analgesic/antipyretic dru-gs: cl- oning, structure, and expression. Proc Natl Acad Sci, 2002, 99: 13926- 13931.
  • 5Steinmeyer J. Pharmacological basis for the thera- py of pain and inflammation with nonsteroidal anti- inflammatory drugs. Arthritis Res, 2000, 2 : 379 385.
  • 6Morita I, Schindler M, Regier MK, et al. Different intracellular locations for prostaglandin endoperox ide H synthase-1 and-2. J Biol Chem, 1995, 270 : 10902- 10908.
  • 7Kis B, Snipes JA, Isse T, et al. Putative cyclooxyg- enase-3 expression in rat brain cells. J Ceerb Blood Flow Metba, 2003, 23 : 1287 - 1292.
  • 8Berenbaum F. COX-3: fact or fancy? Joint Bone Spine, 2004, 71 : 451 -453.
  • 9Sehwab JM, Beiter T, Linder JU, et al. COX-3 a virtual pain target in humans? FASEB J, 2003, 17 : 2174 - 2175.
  • 10Schwab JM, Schluesener H J, Laufer S. COX-3" just another COX or the solitary elusive target of paracetamol. Lancet, 2003, 361 : 981 - 982.

共引文献95

同被引文献68

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部